// App-Quantinova.ai

: A weighted genetic risk score based on 279 signals of association with lung function predicts Chronic Obstructive Pulmonary Disease

Researchers

Presenter

  • Louise Wain

Principal Investigators

  • Nick Shrine

  • Anna Guyatt

  • Vicki Jackson

  • A. Mesut Erzurumluoglu

  • Chiara Batini

  • Nicola Reeve

  • Brian Hobbs

  • Michael Cho

  • David Strachan

  • Andrew Morris

  • Ian Hall

  • Martin Tobin

Medical Centers

  • Department of Oncology, University of Leicester, Leicester, United Kingdom

  • Channing Division of Network Medicine and Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, United States of America

  • Populuation Health Research Institute, St George's, University of London, London, United Kingdom,

  • Department of Biostatistics, University of Liverpool, Liverpool, United Kingdom

  • Division of Pathology, University of Nottingham, Nottingham, United Kingdom

Locations

  • United Kingdom

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A